Differential effects of reserpine and tetrabenazine on rat striatal synaptosomal dopamine biosynthesis and synaptosomal dopamine pools
- PMID: 870679
Differential effects of reserpine and tetrabenazine on rat striatal synaptosomal dopamine biosynthesis and synaptosomal dopamine pools
Abstract
Rat striatal dopamine (DA) levels and synaptosomal DA synthesis were determined after the administration of the catecholamine-depleting agents reserpine (RES) and tetrabenazine (TBZ). Striatal synaptosomal DA synthesis remained unchanged from control levels after Res administration over a wide range of doses (0.5-5 mg/kg) and times (up to 48 hour). In contrast, after TBZ administration, DA synthesis rapidly increased to values greater than 200% of control values, then returned to control levels. The changes in DA synthesis inversely paralleled the depletion of and recovery of striatal DA levels. The increased levels of DA synthesis did not appear to originate with alterations either in the kinetic properties of tyrosine hydroxylase or in the availability of exogenous or endogenous tyrosine. To assess the contribution of synaptosomal DA pools to the regulation of DA synthesis in tissue preparations from RES-or TBZ-pretreated animals, synaptosomal DA synthesis was assessed in the presence of DA releasing agents and compared with analogous experimental manipulations on tissue preparations from animals pretreated with alpha-methyltyrosine or the monoamine oxidase inhibitor, clorgyline. The data are consistent with a differential in vivo interaction of RES and TBZ with a nerve ending pool of DA which participates in end-product inhibition of tyrosine hydroxylase.
Similar articles
-
Tetrabenazine, an amine-depleting drug, also blocks dopamine receptors in rat brain.J Pharmacol Exp Ther. 1983 Jun;225(3):515-21. J Pharmacol Exp Ther. 1983. PMID: 6864517
-
Effects of in vivo amphetamine administration on dopamine synthesis regulation in rat brain striatal synaptosomes.J Pharmacol Exp Ther. 1981 Jun;217(3):686-91. J Pharmacol Exp Ther. 1981. PMID: 7229999
-
Increase of dopamine synthesis in synaptosomes from rats treated with neuroleptics or reserpine.Med Biol. 1982 Feb;60(1):38-41. Med Biol. 1982. PMID: 6121960
-
Compartmentation of synaptosomal dopamine.Adv Biochem Psychopharmacol. 1978;19:57-73. Adv Biochem Psychopharmacol. 1978. PMID: 358787 Review. No abstract available.
-
Tetrabenazine, a monoamine-depleting drug used in the treatment of hyperkinetic movement disorders.Am J Geriatr Pharmacother. 2010 Aug;8(4):331-73. doi: 10.1016/j.amjopharm.2010.08.006. Am J Geriatr Pharmacother. 2010. PMID: 20869622 Review.
Cited by
-
Dopamine Secretion Is Mediated by Sparse Active Zone-like Release Sites.Cell. 2018 Feb 8;172(4):706-718.e15. doi: 10.1016/j.cell.2018.01.008. Epub 2018 Feb 1. Cell. 2018. PMID: 29398114 Free PMC article.
-
Polychlorinated biphenyls alter extraneuronal but not tissue dopamine concentrations in adult rat striatum: an in vivo microdialysis study.Environ Health Perspect. 2002 Nov;110(11):1113-7. doi: 10.1289/ehp.021101113. Environ Health Perspect. 2002. PMID: 12417482 Free PMC article.
-
Effect of Saraswatarishta in animal models of behavior despair.J Ayurveda Integr Med. 2014 Jul;5(3):141-7. doi: 10.4103/0975-9476.140469. J Ayurveda Integr Med. 2014. PMID: 25336844 Free PMC article.
-
An escalating dose/multiple high-dose binge pattern of amphetamine administration results in differential changes in the extracellular dopamine response profiles in caudate-putamen and nucleus accumbens.J Neurosci. 1997 Jun 1;17(11):4441-7. doi: 10.1523/JNEUROSCI.17-11-04441.1997. J Neurosci. 1997. PMID: 9151761 Free PMC article.